AU2002338666A1 - Multiplication of viruses in a cell culture - Google Patents

Multiplication of viruses in a cell culture

Info

Publication number: AU2002338666A1
Authority: AU; Australia
Prior art keywords: viruses; multiplication; cell culture; culture; cell
Prior art date: 2001-09-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002338666A

Other versions

AU2002338666B2 (en

Inventor

Christian Frech

Jens-Peter Gregersen

Holger Lubben

Jurgen Vorlop

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GSK Vaccines GmbH

Original Assignee

Novartis Vaccines and Diagnostics GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-12

Filing date

2002-09-11

Publication date

2003-06-19

2001-09-12 Priority claimed from DE10144903A external-priority patent/DE10144903A1/en

2002-09-11 Application filed by Novartis Vaccines and Diagnostics GmbH filed Critical Novartis Vaccines and Diagnostics GmbH

2003-06-19 Publication of AU2002338666A1 publication Critical patent/AU2002338666A1/en

2008-11-20 Application granted granted Critical

2008-11-20 Publication of AU2002338666B2 publication Critical patent/AU2002338666B2/en

2009-04-23 Assigned to Noartis Vaccines and Diagnostics GmbH & Co. KG reassignment Noartis Vaccines and Diagnostics GmbH & Co. KG Alteration of Name(s) in Register under S187 Assignors: CHIRON BEHRING GMBH & CO.

2011-07-14 Assigned to NOVARTIS VACCINES AND DIAGNOSTICS GMBH reassignment NOVARTIS VACCINES AND DIAGNOSTICS GMBH Request to Amend Deed and Register Assignors: NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO. KG

2022-09-11 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002338666A 2001-09-12 2002-09-11 Multiplication of viruses in a cell culture Ceased AU2002338666B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10144903A DE10144903A1 (en)	2001-09-12	2001-09-12	Replication of virus in cell cultures, useful for preparing vaccines and diagnostic reagents, where replication of cells and virus is simultaneous
DE10144903.8		2001-09-12
PCT/EP2002/010207 WO2003023025A1 (en)	2001-09-12	2002-09-11	Multiplication of viruses in a cell culture

Publications (2)

Publication Number	Publication Date
AU2002338666A1 true AU2002338666A1 (en)	2003-06-19
AU2002338666B2 AU2002338666B2 (en)	2008-11-20

Family

ID=7698761

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002338666A Ceased AU2002338666B2 (en)	2001-09-12	2002-09-11	Multiplication of viruses in a cell culture

Country Status (16)

Country	Link
US (1)	US20050118698A1 (en)
EP (1)	EP1427817B1 (en)
JP (2)	JP2005502357A (en)
KR (1)	KR100968141B1 (en)
AT (1)	ATE466932T1 (en)
AU (1)	AU2002338666B2 (en)
BR (1)	BR0212469A (en)
CA (1)	CA2456561A1 (en)
CY (1)	CY1110716T1 (en)
DE (2)	DE10144903A1 (en)
DK (1)	DK1427817T3 (en)
ES (1)	ES2345606T3 (en)
NZ (1)	NZ532203A (en)
PT (1)	PT1427817E (en)
SI (1)	SI1427817T1 (en)
WO (1)	WO2003023025A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ551640A (en) *	2004-05-20	2010-05-28	Id Biomedical Corp	Process for the production of an influenza vaccine
EP2578229B1 (en)	2004-09-09	2013-07-10	Novartis Vaccines and Diagnostics GmbH	Decreasing potential iatrogenic risks associated with vaccine antigens
CN101365480B (en)	2005-11-01	2014-11-05	诺华疫苗和诊断有限两合公司	Cell-derived virus vaccines with reduced residual cellular DNA levels via β-propiolactone treatment
HUE051122T2 (en)	2005-11-04	2021-03-01	Seqirus Uk Ltd	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
WO2007052058A1 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
EA014028B1 (en)	2005-11-04	2010-08-30	Новартис Вэксинс Энд Диагностикс Срл	Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines
AU2006310163B2 (en)	2005-11-04	2011-09-15	Seqirus UK Limited	Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
NZ592713A (en)	2005-11-04	2012-12-21	Novartis Vaccines & Diagnostic	Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9
CN101448523A (en)	2006-03-24	2009-06-03	诺华疫苗和诊断有限两合公司	Storage of influenza vaccines without refrigeration
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
EP4585610A3 (en) *	2006-09-11	2025-09-24	Seqirus UK Limited	Making influenza virus vaccines without using eggs
EP2069480B1 (en)	2006-09-15	2014-03-19	MedImmune, LLC	Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
CN101784283A (en)	2007-06-27	2010-07-21	诺华有限公司	Low-additive influenza vaccines
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
CN103952376A (en)	2008-09-24	2014-07-30	米迪缪尼有限公司	Methods for cultivating cells, propagating and purifying viruses
JP5548207B2 (en)	2008-09-24	2014-07-16	メディミューン，エルエルシー	Virus purification method
WO2010052214A2 (en)	2008-11-05	2010-05-14	Glaxosmithkline Biologicals S.A.	Novel method
CN102548577A (en)	2009-04-27	2012-07-04	诺华有限公司	Adjuvanted vaccines for protecting against influenza
JP5871806B2 (en) *	2009-10-20	2016-03-01	ノバルティスアーゲー	Improved reverse genetics for virus rescue
BR112012026095A2 (en)	2010-04-14	2015-09-15	Emd Millipore Corp	methods of producing high purity virus stocks and high titers and methods of using them.
EP2566323A2 (en)	2010-05-06	2013-03-13	Novartis AG	Organic peroxide compounds for microorganism inactivation
EP2571520B1 (en)	2010-05-21	2018-04-04	Seqirus UK Limited	Influenza virus reassortment method
AU2011262309B2 (en)	2010-06-01	2015-08-13	Seqirus UK Limited	Concentration of influenza vaccine antigens without lyophilization
AU2011262312B2 (en)	2010-06-01	2015-05-28	Novartis Ag	Concentration and lyophilization of influenza vaccine antigens
US9517205B2 (en)	2010-08-20	2016-12-13	Seqirus UK Limited	Soluble needle arrays for delivery of influenza vaccines
CN103370077B (en) *	2011-02-17	2016-10-26	贝林格尔.英格海姆维特梅迪卡有限公司	Process for commercial scale production of porcine reproductive and respiratory syndrome virus
US9879229B2 (en)	2011-03-14	2018-01-30	National Research Council Of Canada	Method of viral production in cells
GB201216121D0 (en)	2012-09-10	2012-10-24	Novartis Ag	Sample quantification by disc centrifugation
CA2866465A1 (en)	2012-03-06	2013-09-12	Crucell Holland B.V.	Improved vaccination against influenza
US20150210986A1 (en) *	2012-08-24	2015-07-30	Ge Healthcare Bio-Sciences Corp.	Virus purification and formulation process
KR101370512B1 (en)	2013-06-07	2014-03-06	재단법인 목암생명공학연구소	Mdck-derived cell lines suspension-cultured in a protein-free medium and method for propagating virus using the same
BR112017028011A2 (en)	2015-06-26	2018-08-28	Seqirus Uk Ltd	antigenically matched influenza vaccines
CN108027371B (en)	2015-07-07	2020-08-18	思齐乐	Influenza Efficacy Test
CN105561317B (en) *	2015-12-22	2018-03-20	肇庆大华农生物药品有限公司	Recombinant pseudorabies virus vaccine heat-resisting lyophilized protecting agent and preparation method thereof
CN108239619A (en) *	2016-12-23	2018-07-03	甘肃健顺生物科技有限公司	The second order culture process technology of suspension mdck cell related vaccines production
CN108570454A (en) *	2017-11-09	2018-09-25	甘肃健顺生物科技有限公司	MDBK tames suspension process and second order virus production technique
CN108570445A (en) *	2017-11-09	2018-09-25	甘肃健顺生物科技有限公司	PK15 cells tame suspension process and second order virus production technique
CN108570444A (en) *	2017-11-09	2018-09-25	甘肃健顺生物科技有限公司	ST cells tame suspension process and second order virus production technique
MX2022006005A (en)	2019-11-18	2022-10-27	Seqirus Pty Ltd	Method for producing reassortant influenza viruses.
KR102444684B1 (en) *	2020-04-29	2022-09-16	에스케이바이오사이언스(주)	Method for producing influenza virus using single-use cultivation process system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19612966B4 (en) *	1996-04-01	2009-12-10	Novartis Vaccines And Diagnostics Gmbh & Co. Kg	MDCK cells and methods of propagating influenza viruses
EP0878541A4 (en) *	1996-10-18	2001-10-17	Univ Osaka Res Found	ROTAVIRUS ANTIGENS, VACCINES AND MEDICINES FOR DIAGNOSING ROTAVIRUS INFECTION AND METHODS OF PREPARING THE SAME
GB9915413D0 (en) *	1999-07-01	1999-09-01	Glaxo Group Ltd	Propagation method
DE60142506D1 (en) *	2000-03-03	2010-08-19	Chemo Sero Therapeut Res Inst	CELL USED IN SERUM FREE CULTURE, CULTURAL SUSPENSION AND PROCEDURE FOR VIRUS PRODUCTION AS A VACCINATE USING THE CELL

2001
- 2001-09-12 DE DE10144903A patent/DE10144903A1/en not_active Ceased
2002
- 2002-09-11 EP EP02777068A patent/EP1427817B1/en not_active Expired - Lifetime
- 2002-09-11 AT AT02777068T patent/ATE466932T1/en active
- 2002-09-11 SI SI200230909T patent/SI1427817T1/en unknown
- 2002-09-11 PT PT02777068T patent/PT1427817E/en unknown
- 2002-09-11 AU AU2002338666A patent/AU2002338666B2/en not_active Ceased
- 2002-09-11 JP JP2003527090A patent/JP2005502357A/en active Pending
- 2002-09-11 WO PCT/EP2002/010207 patent/WO2003023025A1/en not_active Ceased
- 2002-09-11 DK DK02777068.4T patent/DK1427817T3/en active
- 2002-09-11 BR BR0212469-6A patent/BR0212469A/en not_active IP Right Cessation
- 2002-09-11 NZ NZ532203A patent/NZ532203A/en not_active IP Right Cessation
- 2002-09-11 US US10/487,709 patent/US20050118698A1/en not_active Abandoned
- 2002-09-11 ES ES02777068T patent/ES2345606T3/en not_active Expired - Lifetime
- 2002-09-11 DE DE50214416T patent/DE50214416D1/en not_active Expired - Lifetime
- 2002-09-11 KR KR1020047003711A patent/KR100968141B1/en not_active Expired - Lifetime
- 2002-09-11 CA CA002456561A patent/CA2456561A1/en not_active Abandoned
2010
- 2010-06-25 JP JP2010145663A patent/JP2010246559A/en active Pending
- 2010-07-30 CY CY20101100718T patent/CY1110716T1/en unknown

Publication	Publication Date	Title
AU2002338666A1 (en)	2003-06-19	Multiplication of viruses in a cell culture
AU2002368042A1 (en)	2004-01-23	Photovoltaic cell
AU2001252014A1 (en)	2001-11-12	Photovoltaic cell
IL175353A0 (en)	2006-09-05	Optimized expression of hpv 58 li in yeast
AU2002317418A1 (en)	2003-01-29	Cell enumeration
AU2001254885A1 (en)	2002-02-07	Modified ES cells and ES cell-specific gene
AU2001240126A1 (en)	2001-10-03	Lithium cell
AU2002225997A1 (en)	2002-05-21	Two chamber cell culture vessel
EP1333086A4 (en)	2006-03-08	Cell culture case
AU2003260351A1 (en)	2004-03-19	Cell culture insert
AU2002325758A1 (en)	2003-04-01	Cultured stromal cells and uses thereof
AU2001250036A1 (en)	2001-10-08	Microdroplet cell culture technique
AU6001401A (en)	2001-12-24	Flat lithium cell
AU2001252015A1 (en)	2001-11-20	Photovoltaic cell
AU2002246422A1 (en)	2003-10-20	Cell culture plate and system using the same
AU2003224085A1 (en)	2003-11-03	Waveguide in porous substrates
AU2002225693A1 (en)	2002-05-27	Optimized antitrypsin expression in rice cell culture
AU4771600A (en)	2001-11-26	Cells, culture methods and their uses
AUPR968801A0 (en)	2002-01-24	Improvements in enzyme stability
AU2003260552A1 (en)	2003-12-02	Cell culture device
AU2003258420A1 (en)	2004-03-11	Model epithelial cell cultures
AU2003246257A1 (en)	2004-01-23	Cell culture carrier and cell culture unit
HK1071583A (en)	2005-07-22	Cell culture process
AUPR302801A0 (en)	2001-03-08	Gene suppression in mammalian cells
AU2002235429A1 (en)	2002-07-30	Cell culture vessel